Literature DB >> 11171688

Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.

W Hui1, A D Rowan, T Cawston.   

Abstract

OBJECTIVE: To investigate the effect of insulin-like growth factor 1 (IGF1) on the release of collagen, and the production and expression of matrix metalloproteinases (MMPs) induced by the proinflammatory cytokine interleukin 1alpha (IL1alpha) in combination with oncostatin M (OSM) from bovine nasal cartilage and primary human articular chondrocytes.
METHODS: Human articular chondrocytes and bovine nasal cartilage were cultured with and without IGF1 in the presence of IL1alpha or IL1alpha + OSM. The release of collagen was measured by an assay for hydroxyproline. Collagenase activity was determined with the diffuse fibril assay using 3H acetylated collagen. The expression of MMP-1, MMP-3, MMP-8, MMP-13, and tissue inhibitor of metalloproteinase 1 (TIMP-1) mRNA was analysed by northern blot.
RESULTS: IGF1 can partially inhibit the release of collagen induced by IL1alpha or IL1alpha + OSM from bovine nasal cartilage. This was accompanied by a reduced secretion and activation of collagenase by bovine nasal cartilage. IGF1 can also down regulate IL1alpha or IL1alpha + OSM induced MMP-1, MMP-3, MMP-8, and MMP-13 mRNA expression in human articular chondrocytes and bovine chondrocytes. It had no significant effect on the production and expression of TIMP-1 mRNA in chondrocytes.
CONCLUSION: This study shows for the first time that IGF1 can partially block the release of collagen from cartilage and suggests that down regulation of collagenases by IGF1 may be an important mechanism in preventing cartilage resorption initiated by proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171688      PMCID: PMC1753584          DOI: 10.1136/ard.60.3.254

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  53 in total

1.  MMPs are IGFBP-degrading proteinases: implications for cell proliferation and tissue growth.

Authors:  J L Fowlkes; D M Serra; H Nagase; K M Thrailkill
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

2.  96-Well plate assays for measuring collagenase activity using (3)H-acetylated collagen.

Authors:  P J Koshy; A D Rowan; P F Life; T E Cawston
Journal:  Anal Biochem       Date:  1999-11-15       Impact factor: 3.365

3.  Treatment of canine osteoarthritis with sodium pentosan polysulfate and insulin-like growth factor-1.

Authors:  R A Rogachefsky; D D Dean; D S Howell; R D Altman
Journal:  Ann N Y Acad Sci       Date:  1994-09-06       Impact factor: 5.691

Review 4.  Actions of insulin-like growth factors.

Authors:  E R Froesch; C Schmid; J Schwander; J Zapf
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

5.  Transforming growth factor beta1 blocks the release of collagen fragments from boving nasal cartilage stimulated by oncostatin M in combination with IL-1alpha.

Authors:  W Hui; A D Rowan; T Cawston
Journal:  Cytokine       Date:  2000-06       Impact factor: 3.861

6.  The effect of serum on biosynthesis of proteoglycans by bovine articular cartilage in culture.

Authors:  V C Hascall; C J Handley; D J McQuillan; G K Hascall; H C Robinson; D A Lowther
Journal:  Arch Biochem Biophys       Date:  1983-07-01       Impact factor: 4.013

7.  The effects of insulin-like growth factor-1 on plasminogen activator inhibitor-1 synthesis and secretion: results from in vitro and in vivo studies.

Authors:  S J Padayatty; S Orme; P D Zenobi; M H Stickland; P E Belchetz; P J Grant
Journal:  Thromb Haemost       Date:  1993-12-20       Impact factor: 5.249

8.  Transforming growth factor-beta and insulin-like growth factor-1 restore proteoglycan metabolism of bovine articular cartilage after depletion by retinoic acid.

Authors:  T I Morales
Journal:  Arch Biochem Biophys       Date:  1994-11-15       Impact factor: 4.013

9.  Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants.

Authors:  R L Sah; A C Chen; A J Grodzinsky; S B Trippel
Journal:  Arch Biochem Biophys       Date:  1994-01       Impact factor: 4.013

10.  Transforming growth factor beta 1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes.

Authors:  M Günther; H D Haubeck; E van de Leur; J Bläser; S Bender; I Gütgemann; D C Fischer; H Tschesche; H Greiling; P C Heinrich
Journal:  Arthritis Rheum       Date:  1994-03
View more
  23 in total

1.  Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.

Authors:  Kathryn M Thrailkill; Cindy S Moreau; Gael Cockrell; Pippa Simpson; Rajiv Goel; Paula North; John L Fowlkes; Robert C Bunn
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

2.  Association between dynamic exercise therapy and IGF-1 and IGFBP-3 concentrations in the patients with rheumatoid arthritis.

Authors:  Meltem Alkan Melikoglu; Saliha Karatay; Kazim Senel; Fatih Akcay
Journal:  Rheumatol Int       Date:  2005-06-03       Impact factor: 2.631

3.  Effects of 17 beta-estradiol on the expression of interstitial collagenases-8 and -13 (MMP-8 and MMP-13) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in ovariectomized rat osteoblastic cells.

Authors:  Jian Li; Er-Yuan Liao; Ru-Chun Dai; Qi-You Wei; Xiang-Hang Luo
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

4.  Synergistic effect of IGF-1 and OP-1 on matrix formation by normal and OA chondrocytes cultured in alginate beads.

Authors:  S Chubinskaya; A Hakimiyan; C Pacione; A Yanke; L Rappoport; T Aigner; D C Rueger; R F Loeser
Journal:  Osteoarthritis Cartilage       Date:  2006-11-27       Impact factor: 6.576

5.  Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes.

Authors:  Hee-Jeong Im; Carol Pacione; Susan Chubinskaya; Andre J Van Wijnen; Yubo Sun; Richard F Loeser
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

6.  Increased expression of the Akt/PKB inhibitor TRB3 in osteoarthritic chondrocytes inhibits insulin-like growth factor 1-mediated cell survival and proteoglycan synthesis.

Authors:  John D Cravero; Cathy S Carlson; Hee-Jeong Im; Raghunatha R Yammani; David Long; Richard F Loeser
Journal:  Arthritis Rheum       Date:  2009-02

7.  Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.

Authors:  Andrew D Rowan; Wang Hui; Tim E Cawston; Carl D Richards
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

8.  The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha.

Authors:  Hua Ling; Anneliese D Recklies
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

9.  Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines.

Authors:  P J Koshy; N Henderson; C Logan; P F Life; T E Cawston; A D Rowan
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

10.  Mold-shaped, nanofiber scaffold-based cartilage engineering using human mesenchymal stem cells and bioreactor.

Authors:  Sasa Janjanin; Wan-Ju Li; Meredith T Morgan; Rabie M Shanti; Rocky S Tuan
Journal:  J Surg Res       Date:  2008-01-28       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.